HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

It can also worsen viral infections, such as hepatitis B and mpox. Without any treatment, people with AIDS typically survive about three years. HIV and AIDS are related, in that AIDS is the most ...

The Wistar Institute has launched its HIV Cure and Viral Diseases Center with new lab space on Market Street and a plan to ...

Researchers at the Department of Medicine, Huddinge, have presented new research on how some people with HIV can control the ...

About 21 000 HIV patients have disappeared from Mpumalanga’s treatment system, yet officials remain unclear or deny the ...

A new study found that implementing a specialty pharmacy program at St. Jude Children’s Research Hospital helped more young ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...